Your search for "vector vaccines" return 126 results.
Ceva acquires Vetech Laboratories, Inc. >
Move adds significant poultry vaccine to innovative portfolio
Instituto Sanidad Ganadera, Argentina acquired by Ceva >
New company will build on strong biological expertise and expand Ceva’s platform in South American zone.
Joint Venture agreement between Ceva and Huadu signed in Beijing >
“Ceva Huadu” to become Innovation & R&D platform for biologicals
Dr. Steve Chu joins Ceva after 25 years at Fort Dodge and Elanco >
Addition to talented team positions Ceva for continued growth.
Parasiticides >
75% of all emerging human infectious diseases are of animal origin. Thanks to its products, Ceva fight against the spread of infectious disease that can be transmitted from wild or domestic animals an...
Ceva opens new production facility in Lenexa, Kansas >
May 3, 2011, Lenexa, Kan. –– Ceva Animal Health is pleased to announce the May 3, 2011 opening of a new poultry vaccine production facility at its Biomune Campus in Lenexa, Kansas.
Ceva finishes first decade of success with strong growth >
2010 results demonstrate global ability to generate sales and earnings
Ceva launches latest of its Vector Vaccines at VIV Asia 2011 >
VECTORMUNE HVT- NDV® generates strong interest at symposium organised to present new strategies to combat Newcastle Disease.
Vector vaccines symposium - 23th September 2010 >
CEVA will hold its first vector vaccines symposium in San Diego, USA from october 6-8th2010. Together with presenting its advanced technology, the forum will encourage the sharing of worldwide experie...
USA: Ceva acquires Summit VetPharm, LLC - 26th August 2010 >
LENEXA, Kan.— Ceva, a global veterinary pharmaceutical group, is pleased to announce the company has entered into an agreement with Sumitomo Corporation of America, and Sumitomo Corporation, to acquir...